A polymerase chain reaction screening strategy for the promoter of the canine dystrophin gene

American Journal of Veterinary Research

Volumn 60, Issue 9, 1999, Pages 1040-1046

  Schatzberg, S ^a   Olby, V ^a   Steingold, S ^a   Keene, B ^a   Atkins, C ^a   Meurs, K ^b   Solomon, G ^c   Goedegebuure, S A ^d   Wilton, S ^e   Sharp, N ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d UTRECHT UNIVERSITY   (Netherlands)

^e PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DYSTROPHIN; PRIMER DNA;

AGAR GEL ELECTROPHORESIS; ANIMAL; ANIMAL DISEASE; ANIMAL MUSCULAR DYSTROPHY; ARTICLE; CHEMISTRY; CONGESTIVE CARDIOMYOPATHY; DNA SEQUENCE; DOG; DOG DISEASE; EXON; GENETICS; HUMAN; METHODOLOGY; MOLECULAR CLONING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PURKINJE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SKELETAL MUSCLE; SOUTHERN BLOTTING;

ANIMALS; BASE SEQUENCE; BLOTTING, SOUTHERN; CARDIOMYOPATHY, DILATED; CLONING, MOLECULAR; DNA; DNA PRIMERS; DOG DISEASES; DOGS; DYSTROPHIN; ELECTROPHORESIS, AGAR GEL; EXONS; HUMANS; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; PROMOTER REGIONS (GENETICS); PURKINJE CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 0033191040     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Milasin J, Muntoni F, Severini G, et al. A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol Genet 1996;5:73-79.
2. Muntoni F, Cau M, Ganau A, et al. Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 1993;329:921-925.
3. Yoshida K, Ikeda S, Nakamura A, et al. Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy. Muscle Nerve 1993;16:1161-1166.
4. Keister D, Kittleson M, Bonagura J, et al. Milrinone. A clinical trial in 29 dogs with moderate to severe congestive heart failure. J Vet Intern Med 1990;4:79-86.
5. Calvert C. Dilated congestive cardiomyopathy in Doberman Pinschers. Compend Contin Educ Pract Vet 1986;8:417-429.
6. Monnet E, Orton E, Salman M, et al. Idiopathic dilated cardiomyopathy in dogs: survival and prognostic indicators. J Vet Intern Med 1995;9:12-17.
7. Hill B. Canine idiopathic congestive cardiomyopathy. Compend Contin Educ Pract Vet 1981;3:615-621.
8. Harpster N. Boxer cardiomyopathy: a review of the long-term benefits of antiarrhythmic therapy. Vet Clin North Am Small Anim Pract 1991;21:989-1004.
9. Freeman L, Michel K, Brown D, et al. Idiopathic dilated cardiomyopathy in Dalmatians: nine cases (1990-1995). J Am Vet Med Assoc 1996;209:1592-1596.
10. Calvert C, Chapman W, Toal R. Congestive cardiomyopathy in Doberman Pinscher dogs. J Am Vet Med Assoc 1982;181:598-602.
11. Wentink G, van der Linde-Sipman J, Meijer A, et al. Myopathy with a possible X-linked mode of inheritance in a litter of Irish terriers. Vet Pathol 1972;9.328-349.
12. Klamut H, Gangopadhyay S, Worton R, et al Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene. Mol Cell Biol 1990;10:193-205.
13. Gorecki D, Monaco A, Derry J, et al. Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum Mol Genet 1992;1:505-510.
14. Boyce F, Beggs A, Feener C, et al. Dystrophin is transcribed in brain from a distant upstream promoter. Proc Natl Acad Sci U S A 1991;88:1276-1280.
15. Rottman J, Freeman E, Tonkonogy S, et al. A reverse transcription-polymerase chain reaction technique to detect feline cytokine genes. Vet Immunol Immunopathol 1995;45:1-18.
16. Futscher B, Blake L, Gerlach J, et al. Quantitative PCR analysis of mdrl mRNA in multiple myeloma cell lines and clinical specimens. Anal Biochem 1993;213:414-421.
17. Holder E, Maeda M, Bies R. Expression and regulation of the dystrophin Purkinje promoter in human skeletal muscle, heart, and brain. Hum Genet 1996;97:232-239.
18. Nishio H, Takeshima Y, Narita N, et al. Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter. J Clin Invest 1994;94:1037-1042.
19. D'Souza V, Nguyen T, Morris G, et al. A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet 1995;4:837-842.
20. Lidov H, Selig S, Kunkel L. Dp140: a novel 140 kDa CNS transcript from the dystrophin locus. Hum Mol Genet 1995;4:329-335.
21. Byers T, Lidov H, Kunkel L. An alternative dystrophin transcript specific to peripheral nerve. Nat Genet 1993;4:77-81.
22. Bar S, Barnea E, Levy Z, et al. A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution. Biochem J 1990;272:557-560.
23. Winand N, Edwards M, Pradhan D, et al. Deletion of the dystrophin muscle promoter in feline muscular dystrophy. Neuromuscul Disord 1994;4:433-445.
24. Buskin J, Hauschka S. Identification of a myocyte nuclear factor that binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene. Mol Cell Biol 1989;9:2627-2640.
25. Sartorelli V, Hong N, Bishopric N, et al. Myocardial activation of the human cardiac alpha-actin promoter by helix-loop-helix proteins. Proc Natl Acad Sci U S A 1992;89:4047-4051.
26. Amacher S, Buskin J, Hauschka S. Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle. Mol Cell Biol 1993;13: 2753-2764.
27. Galvagni F, Lestingi M, Cartocci E, et al. Serum response factor and protein-mediated DNA bending contribute to transcription of the dystrophin muscle-specific promoter. Mol Cell Biol 1997;17:1731-1743.
28. Bies R, Phelps S, Cortez M, et al. Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development. Nucleic Acids Res 1992;20:1725-1731.
29. Moise N, Valentine B, Brown C, et al. Duchenne's cardiomyopathy in a canine model: electrocardiographic and echocardiographic studies. J Am Coll Cardiol 1991;17:812-820.
30. Nigro G, Comi L, Politano L, et al. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 1990;26:271-277.